This presentation will briefly cover point-of-care testing (POCT) from a historical standpoint. (What are we doing and why did we decide to do it this way?) This presentation will incorporate ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the rapid influenza diagnostic tests market and it is poised to grow by USD 0.89 billion during 2020-2024, at a CAGR of 11% during the forecast ...

Clinicians and nurses in neonatal intensive care units (NICU) across Manchester University NHS Foundation Trust (MFT) are the world’s first to deploy genedrive’s MT-RNR1 ID Kit, a new rapid genetic ...

LumiraDx shares these and other findings from its second annual U.S. survey “Point of Care Diagnostics: A Clinician's View” WALTHAM, Mass., Dec. 08, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy To put it another way ...

The global point-of-care testing (POCT) market is driven by rising patient demand, technological innovation, and supportive regulatory frameworks. Rapid diagnostics, enhanced chronic disease ...

Key market opportunities in the point-of-care influenza diagnostics market include the rising demand for rapid tests due to ...

You don't want to miss this! To permanently access this eBook for free, fill out the short form below. Discover practical strategies for syndemic testing of syphilis, HIV, and HCV in this free eBook.

Thousands of lives could have been saved at relatively little cost, if nursing home operators had made wider use of rapid COVID-19 tests during the pre-vaccine days of the pandemic, a study published ...